World-first trial to assess ‘life-extending’ cannabis-based drug for thousands with aggressive brain tumours
BHP founder member the University of Birmingham will co-ordinate a major UK trial to analyse the efficacy of cannabis-based drug Sativex in treating the most aggressive form of brain tumours.
The …
Rheumatology Research Group awarded five year EULAR Centre of Excellence Status
The Rheumatology Research Group (RRG) at BHP founder-member the University of Birmingham has been awarded five-year EULAR Centre of Excellence status for the second time in a row.
EULAR (European …
New study aims to improve healthcare for pregnant women with multiple health conditions
BHP founder-member the University of Birmingham is leading a new three-year UK-wide study aimed at improving healthcare and outcomes for pregnant women who have two or more active long-term health …
UHB and Cambridge University Hospitals win government funding for ground-breaking AI in radiotherapy
A machine learning technology that helps cut the time patients wait for life-saving cancer treatment has been successful in the latest round of the Artificial Intelligence (AI) in Health and Care A…
£1.5m funding for youth mental health research
The Institute for Mental Health at BHP founder member the University of Birmingham has been awarded £1.5M from the Wolfson Foundation to fund a research centre focused on supporting youth mental he…
Urine test for bladder cancer to be developed by University of Birmingham and Nonacus
BHP founder-member the University of Birmingham and Nonacus, a provider of genetic testing products for precision medicine and liquid biopsy, have partnered to develop a non-invasive test for bladd…